Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Du bruger tilsyneladende en bredere skærm. Vil du gerne give denne side en bredere visningsoplevelse?

Audientes – Presentation of Q4/end of year 2023 report

Af Michael FriisHead of Equities
Audientes

You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.

Audientes expects to release its Q4 and FY 2023 results on 22 February 2024. The next day 23 February 2024 at 10:00, Audientes’ CEO Steen Thygesen will present the results and answer questions in a virtual live event.

Besides the financial results for the last quarter of the year, the focus of the event will be on what to expect in 2024. In 2024 the company expects to launch in China and Japan, a new business segment aiming to diversify its business by licensing its software and hardware platform is put to the test, and they aim at developing new products in other form-factors.

Furthermore, the capital situation and further funding needs are also expected to be in focus during the event.

Audientes is a Danish hearing health company specializing in smart, self-fitting, and affordable hearing aids and advanced hearables. Audientes’ hearing aid solution, Ven™ by Audientes, is available for purchase in the Indian and Nepalese markets and will be introduced in other markets in the coming years. Companion by Audientes is an advanced hearable, a consumer electronics product, that is commercially available in Europe and later in 2024 in Japan, China, and other markets.

Disclaimer: HC Andersen Capital receives payment from Audientes for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 13.14, 12 February 2024.

Seneste videoer

AKTIER MED FRIIS - UGE 2 2026
09.01.2026, 12.00
HCA Morgenbørs 09/01 - Futures peger op i Europa og fokus på afgørelse om Trumps tariffer
09.01.2026, 09.28 Gubra
Herantis Pharma Plc, Phase 1b biomarker data webcast
08.01.2026, 11.00 Herantis Pharma
HCA Morgenbørs 08/01 - Røde futures og fokus på kursmålsjusteringer
08.01.2026, 09.18 Novo Nordisk
HCA Morgenbørs 07/01 - Vi ser ind i en blandet udvikling på de globale futures-markeder med Europa i plus og USA i minus
07.01.2026, 09.58 RTX
Vis alle videoer
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.